3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
169
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Recurrence
28
Leukemia
24
Vomiting
23
Neoplasms, Plasma Cell
20
Lymphoma
18
Neoplasms
16
Nausea
13
Burkitt Lymphoma
11
Prostatic Neoplasms
8
Immunoglobulin Light-chain Amyloidosis
7
Carcinoma, Non-Small-Cell Lung
6
Lymphoma, Follicular
5
Lung Neoplasms
5
Hodgkin Disease
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Small Cell Lung Carcinoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Paraproteinemias
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Fallopian Tube Neoplasms
3
Interventions
Radiotherapy
8
Cisplatin
3
Carboplatin
3
sargramostim
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Donepezil
2
cevimeline
1
beta Carotene
1
alpha-Tocopherol
1
Zinc Sulfate
1
Vortioxetine
1
Vitamin E
1
Standard of Care
1
Sodium Chloride
1
Salts
1
Radiotherapy, Conformal
1
Radiosurgery
1
Oxygen
1
Oxaliplatin
1
Neck Dissection
1
Mometasone Furoate
1
Meditation
1
Hyperbaric Oxygenation
1
Glutamine
1
G(M1) Ganglioside
1
Filgrastim
1
Fibroblast Growth Factor 7
1
Etoposide
1
Erythropoietin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Radiation Injuries
×
Dexamethasone
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled